AgomAb Therapeutics NV (AGMB)
11.79
-0.29
(-2.40%)
USD |
NASDAQ |
Sep 18, 11:42
AgomAb Therapeutics Net Income (Quarterly) : -20.25M for Dec. 31, 2025
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -20.25M |
| Date | Value |
|---|---|
| December 31, 2024 | -12.51M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.164M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| GB Sciences, Inc. | -- |
| Invion Ltd. | -- |
| Arvinas, Inc. | 169.40M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 20.25M |
| EPS Diluted (Quarterly) | -0.4156 |
| Enterprise Value | 459.55M |
| Earnings Yield | -5.70% |